Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR GLIPIZIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Glipizide

Subscribe to access the full database, or Sign up for a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00094770 ↗	An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-09-01	The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes).
NCT00095056 ↗	An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-10-01	The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
NCT00116831 ↗	Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes	Completed	GlaxoSmithKline	Phase 3	2005-01-01	The purpose of this study is to test the safety and effectiveness of rosiglitazone against a sulfonylurea in reducing or slowing the development of atherosclerosis in the blood vessels of the heart.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Glipizide

Condition Name

Chart
Table

Condition Name for Glipizide
Intervention	Trials
Diabetes Mellitus, Type 2	9
Type 2 Diabetes Mellitus	8
Type 2 Diabetes	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Glipizide
Intervention	Trials
Diabetes Mellitus	28
Diabetes Mellitus, Type 2	25
Renal Insufficiency, Chronic	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Glipizide

Trials by Country

Map
Table

Trials by Country for Glipizide
Location	Trials
United States	92
India	18
Mexico	17
Germany	14
Italy	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Glipizide
Location	Trials
North Dakota	6
California	5
Texas	5
Illinois	5
Pennsylvania	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Glipizide

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Glipizide
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	13
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Glipizide
Clinical Trial Phase	Trials
Completed	32
Unknown status	4
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Glipizide

Sponsor Name

Chart
Table

Sponsor Name for Glipizide
Sponsor	Trials
Merck Sharp & Dohme Corp.	11
Canadian Network for Observational Drug Effect Studies, CNODES	3
Canadian Institutes of Health Research (CIHR)	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Glipizide
Sponsor	Trials
Other	30
Industry	29
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Harvard Business School

AstraZeneca

Express Scripts

McKinsey

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.